Development of Potent and Selective Janus Kinase 2/3 Directing PG?PROTACs

Alcock, Lisa J.; Chang, Yunchao; Jarusiewicz, Jamie A.; Actis, Marisa; Nithianantham, Stanley; Mayasundari, Anand; Min, Jaeki; Maxwell, Dylan; Hunt, Jeremy; Smart, Brandon; Yang, Jun J.; Nishiguchi, Gisele; Fischer, Marcus; Mullighan, Charles G.; Rankovic, Zoran

doi:10.1021/acsmedchemlett.1c00650

Title: Development of Potent and Selective Janus Kinase 2/3 Directing PG?PROTACs

Journal Article · 01 February 2022 · ACS Med. Chem. Lett.

DOI:https://doi.org/10.1021/acsmedchemlett.1c00650· OSTI ID:1856384

Alcock, Lisa J.; Chang, Yunchao; Jarusiewicz, Jamie A.; Actis, Marisa; Nithianantham, Stanley; Mayasundari, Anand; Min, Jaeki; Maxwell, Dylan; Hunt, Jeremy; Smart, Brandon; Yang, Jun J.; Nishiguchi, Gisele; Fischer, Marcus; Mullighan, Charles G.; Rankovic, Zoran

Cite

Export

Save

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; NCI; OTHER

OSTI ID:: 1856384

Journal Information:: ACS Med. Chem. Lett., Vol. 13, Issue (3)

Country of Publication:: United States

Language:: ENGLISH

References (25)

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia Roberts, Kathryn G.; Li, Yongjin; Payne-Turner, Debbie New England Journal of Medicine, Vol. 371, Issue 11 https://doi.org/10.1056/NEJMoa1403088	journal	September 2014
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia Roberts, Kathryn G.; Morin, Ryan D.; Zhang, Jinghui Cancer Cell, Vol. 22, Issue 2 https://doi.org/10.1016/j.ccr.2012.06.005	journal	August 2012
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia Yoda, Akinori; Yoda, Yuka; Chiaretti, Sabina Proceedings of the National Academy of Sciences, Vol. 107, Issue 1 https://doi.org/10.1073/pnas.0911726107	journal	December 2009
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia Russell, Lisa J.; Capasso, Melania; Vater, Inga Blood, Vol. 114, Issue 13 https://doi.org/10.1182/blood-2009-03-208397	journal	September 2009
Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia Mullighan, Charles G.; Collins-Underwood, J. Racquel; Phillips, Letha A. A. Nature Genetics, Vol. 41, Issue 11 https://doi.org/10.1038/ng.469	journal	October 2009
High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults Roberts, Kathryn G.; Gu, Zhaohui; Payne-Turner, Debbie Journal of Clinical Oncology, Vol. 35, Issue 4 https://doi.org/10.1200/JCO.2016.69.0073	journal	February 2017
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia Tasian, Sarah K.; Doral, Michelle Y.; Borowitz, Michael J. Blood, Vol. 120, Issue 4 https://doi.org/10.1182/blood-2011-12-389932	journal	July 2012
Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy Koppikar, Priya; Bhagwat, Neha; Kilpivaara, Outi Nature, Vol. 489, Issue 7414 https://doi.org/10.1038/nature11303	journal	July 2012
New Chemical Modalities and Strategic Thinking in Early Drug Discovery Blanco, Maria-Jesus; Gardinier, Kevin M. ACS Medicinal Chemistry Letters, Vol. 11, Issue 3 https://doi.org/10.1021/acsmedchemlett.9b00582	journal	January 2020
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones Ishida, Tasuku; Ciulli, Alessio SLAS Discovery, Vol. 26, Issue 4 https://doi.org/10.1177/2472555220965528	journal	April 2021
Degradation of Janus kinases in CRLF2 -rearranged acute lymphoblastic leukemia Chang, Yunchao; Min, Jaeki; Jarusiewicz, Jamie A. Blood, Vol. 138, Issue 23 https://doi.org/10.1182/blood.2020006846	journal	December 2021
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase Matyskiela, Mary E.; Lu, Gang; Ito, Takumi Nature, Vol. 535, Issue 7611 https://doi.org/10.1038/nature18611	journal	June 2016
Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders Ishoey, Mette; Chorn, Someth; Singh, Natesh ACS Chemical Biology, Vol. 13, Issue 3 https://doi.org/10.1021/acschembio.7b00969	journal	January 2018
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators Nishiguchi, Gisele; Keramatnia, Fatemeh; Min, Jaeki Journal of Medicinal Chemistry, Vol. 64, Issue 11 https://doi.org/10.1021/acs.jmedchem.0c01313	journal	May 2021
Hi-JAK-ing the ubiquitin system: The design and physicochemical optimisation of JAK PROTACs Shah, Rishi R.; Redmond, Joanna M.; Mihut, Andrei Bioorganic & Medicinal Chemistry, Vol. 28, Issue 5 https://doi.org/10.1016/j.bmc.2020.115326	journal	March 2020
Phenyl‐Glutarimides: Alternative Cereblon Binders for the Design of PROTACs Min, Jaeki; Mayasundari, Anand; Keramatnia, Fatemeh Angewandte Chemie International Edition, Vol. 60, Issue 51 https://doi.org/10.1002/anie.202108848	journal	November 2021
Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof Davis, Ryan R.; Li, Baoli; Yun, Sang Y. Journal of Medicinal Chemistry, Vol. 64, Issue 4 https://doi.org/10.1021/acs.jmedchem.0c01952	journal	February 2021
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders Yang, Jiuling; Li, Yangbing; Aguilar, Angelo Journal of Medicinal Chemistry, Vol. 62, Issue 21 https://doi.org/10.1021/acs.jmedchem.9b00846	journal	September 2019
De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives Heim, Christopher; Pliatsika, Dimanthi; Mousavizadeh, Farnoush Journal of Medicinal Chemistry, Vol. 62, Issue 14 https://doi.org/10.1021/acs.jmedchem.9b00454	journal	June 2019
Thalidomide mimics uridine binding to an aromatic cage in cereblon Hartmann, Marcus D.; Boichenko, Iuliia; Coles, Murray Journal of Structural Biology, Vol. 188, Issue 3 https://doi.org/10.1016/j.jsb.2014.10.010	journal	December 2014
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery Laskowski, Roman A.; Swindells, Mark B. Journal of Chemical Information and Modeling, Vol. 51, Issue 10 https://doi.org/10.1021/ci200227u	journal	October 2011
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos Matyskiela, Mary E.; Zhang, Weihong; Man, Hon-Wah Journal of Medicinal Chemistry, Vol. 61, Issue 2 https://doi.org/10.1021/acs.jmedchem.6b01921	journal	April 2017
Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes Tomoyasu, Chihiro; Imamura, Toshihiko; Tomii, Toshihiro International Journal of Hematology, Vol. 108, Issue 3 https://doi.org/10.1007/s12185-018-2474-7	journal	May 2018
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias Kim, Sang-Kyu; Knight, Deborah A.; Jones, Lisa R. Genes & Development, Vol. 32, Issue 11-12 https://doi.org/10.1101/gad.307504.117	journal	June 2018
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia Bӧhm, Julia W.; Sia, Keith C. S.; Jones, Connor Leukemia, Vol. 35, Issue 11 https://doi.org/10.1038/s41375-021-01248-8	journal	April 2021

Similar Records

Development of Selective Covalent Janus Kinase 3 Inhibitors

Journal Article · 2015 · Journal of Medicinal Chemistry · OSTI ID:1856384

Tan, Li; Akahane, Koshi; McNally, Randall; +16 more

Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design

Journal Article · 2017 · Journal of Medicinal Chemistry · OSTI ID:1856384

Lee, Katherine L.; Ambler, Catherine M.; Anderson, David R.; +46 more

Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia

Journal Article · 2023 · Journal of Medicinal Chemistry · OSTI ID:1856384

Kaneshige, Atsunori; Bai, Longchuan; Wang, Mi; +8 more

Title: Development of Potent and Selective Janus Kinase 2/3 Directing PG?PROTACs

Citation Formats

References (25)

Similar Records

Related Subjects